Analysis of inflammatory signals in Japanese children with Crohn's disease

Yoshito Fujitake1, Yoshikazu Ohtsuka, Tamaki Ikuse

  • 1Department of Pediatrics and Adolescent Medicine, Juntendo University School of Medicine, Hongo, Tokyo; Department of Pediatrics, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Insights

This study investigated Crohn

Area of Science:

  • Immunology
  • Gastroenterology
  • Pediatrics

Background:

  • Crohn's disease (CD) pathogenesis involves Th1 and Th17 cytokines.
  • The exact cause of pediatric CD in Japan remains unclear.
  • This study investigates pro-inflammatory cytokines in Japanese pediatric CD patients.

Purpose of the Study:

  • To examine pro-inflammatory cytokine and signaling molecule expression in pediatric CD patients.
  • To differentiate between acute and remission phases of pediatric CD in Japan.
  • To explore the role of Th1 and Th17 signaling in pediatric CD pathogenesis.

Main Methods:

  • Serum cytokine assays were performed on 11 acute-phase and 20 remission-phase pediatric CD patients.
  • Intestinal mucosal samples were analyzed for signaling molecule expression via real-time PCR.
  • Examined Th1, Th2, Th17, and regulatory T-cell signaling molecules in pediatric CD patients and controls.

Main Results:

  • Elevated serum interleukin-6 and tumor necrosis factor-α in acute-phase pediatric CD patients.
  • Increased mucosal expression of interferon-γ, STAT4, and TGF-β1 in acute-phase pediatric CD.
  • Significant differences observed when comparing acute CD, remission CD, and healthy controls.

Conclusions:

  • Th1 and Th17 signaling pathways are implicated in pediatric CD pathogenesis in Japan.
  • Findings highlight the role of specific cytokines in acute pediatric CD.
  • Further research is warranted to elucidate precise mechanisms.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...